For help on how to get the results you want, see our search tips.
1577 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Shortages Remove Shortages filter
Direct healthcare professional communication Remove Direct healthcare professional communication filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Pantozol Control (updated)
pantoprazole, Gastroesophageal Reflux
Date of authorisation: 11/06/2009, Revision: 15, Authorised, Last updated: 08/03/2021 -
List item
Human medicine European public assessment report (EPAR): Somac Control (updated)
pantoprazole, Gastroesophageal Reflux
Date of authorisation: 12/06/2009, Revision: 14, Authorised, Last updated: 08/03/2021 -
List item
Human medicine European public assessment report (EPAR): Instanyl (updated)
Fentanyl citrate, Pain, Cancer
Date of authorisation: 20/07/2009, Revision: 27, Authorised, Last updated: 08/03/2021 -
List item
Human medicine European public assessment report (EPAR): Spravato (updated)
esketamine hydrochloride, Depressive Disorder
Date of authorisation: 18/12/2019,
, Revision: 2, Authorised, Last updated: 08/03/2021
-
List item
Human medicine European public assessment report (EPAR): Vargatef (updated)
nintedanib, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 21/11/2014, Revision: 14, Authorised, Last updated: 08/03/2021 -
List item
Human medicine European public assessment report (EPAR): Gardasil 9 (updated)
human papillomavirus vaccine [types 6, 11, 16, 18, 31, 33, 45, 52, 58] (recombinant, adsorbed), Condylomata Acuminata, Papillomavirus Infections, Immunization, Uterine Cervical Dysplasia
Date of authorisation: 09/06/2015, Revision: 15, Authorised, Last updated: 08/03/2021 -
List item
Human medicine European public assessment report (EPAR): Vyxeos liposomal (previously known as Vyxeos) (updated)
daunorubicin hydrochloride, cytarabine, Leukemia, Myeloid, Acute
Date of authorisation: 23/08/2018,
, Revision: 5, Authorised, Last updated: 08/03/2021
-
List item
Human medicine European public assessment report (EPAR): Vizarsin (updated)
sildenafil, Erectile Dysfunction
Date of authorisation: 21/09/2009,
, Revision: 16, Authorised, Last updated: 05/03/2021
-
List item
Human medicine European public assessment report (EPAR): Tecentriq (updated)
atezolizumab, Carcinoma, Transitional Cell, Carcinoma, Non-Small-Cell Lung, Urologic Neoplasms, Breast Neoplasms, Small Cell Lung Carcinoma
Date of authorisation: 20/09/2017,, Revision: 13, Authorised, Last updated: 05/03/2021
-
List item
Human medicine European public assessment report (EPAR): Iressa (updated)
gefitinib, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 24/06/2009, Revision: 14, Authorised, Last updated: 05/03/2021 -
List item
Human medicine European public assessment report (EPAR): Trizivir (updated)
abacavir (as sulfate), lamivudine, zidovudine, HIV Infections
Date of authorisation: 27/12/2000, Revision: 36, Authorised, Last updated: 05/03/2021 -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Accord (updated)
pemetrexed disodium hemipentahydrate, Carcinoma, Non-Small-Cell Lung, Mesothelioma
Date of authorisation: 18/01/2016,, Revision: 6, Authorised, Last updated: 05/03/2021
-
List item
Human medicine European public assessment report (EPAR): Integrilin (updated)
eptifibatide, Angina, Unstable, Myocardial Infarction
Date of authorisation: 01/07/1999, Revision: 25, Authorised, Last updated: 05/03/2021 -
List item
Human medicine European public assessment report (EPAR): Xtandi (updated)
enzalutamide, Prostatic Neoplasms
Date of authorisation: 21/06/2013,
Date of refusal: 26/04/2013, Revision: 16, Authorised, Last updated: 05/03/2021 -
List item
Human medicine European public assessment report (EPAR): Azomyr (updated)
desloratadine, Rhinitis, Allergic, Perennial, Urticaria, Rhinitis, Allergic, Seasonal
Date of authorisation: 15/01/2001, Revision: 45, Authorised, Last updated: 04/03/2021 -
List item
Human medicine European public assessment report (EPAR): Vipdomet (updated)
alogliptin benzoate, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 18/09/2013, Revision: 7, Authorised, Last updated: 04/03/2021 -
List item
Human medicine European public assessment report (EPAR): Comirnaty (updated)
Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2, COVID-19 virus infection
Date of authorisation: 21/12/2020,, 
, Revision: 3, Authorised, Last updated: 04/03/2021
-
List item
Human medicine European public assessment report (EPAR): COVID-19 Vaccine Moderna (updated)
CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2), COVID-19 virus infection
Date of authorisation: 06/01/2021,, , Authorised, Last updated: 04/03/2021
-
List item
Human medicine European public assessment report (EPAR): Xgeva (updated)
denosumab, Fractures, Bone, Neoplasm Metastasis
Date of authorisation: 13/07/2011, Revision: 21, Authorised, Last updated: 04/03/2021 -
List item
Human medicine European public assessment report (EPAR): Nimenrix (updated)
Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group W-135 polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group Y polysaccharide conjugated to tetanus toxoid, Meningitis, Meningococcal
Date of authorisation: 20/04/2012, Revision: 32, Authorised, Last updated: 04/03/2021 -
List item
Human medicine European public assessment report (EPAR): Glubrava (updated)
metformin hydrochloride, pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 11/12/2007, Revision: 17, Authorised, Last updated: 04/03/2021 -
List item
Human medicine European public assessment report (EPAR): Competact (updated)
pioglitazone, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 28/07/2006, Revision: 18, Authorised, Last updated: 04/03/2021 -
List item
Human medicine European public assessment report (EPAR): Actos (updated)
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 13/10/2000, Revision: 27, Authorised, Last updated: 04/03/2021 -
List item
Human medicine European public assessment report (EPAR): Ninlaro (updated)
ixazomib citrate, Multiple Myeloma
Date of authorisation: 21/11/2016,, , , Revision: 9, Authorised, Last updated: 03/03/2021
-
List item
Human medicine European public assessment report (EPAR): Maviret (updated)
glecaprevir, pibrentasvir, Hepatitis C, Chronic
Date of authorisation: 26/07/2017,, 
, Revision: 11, Authorised, Last updated: 03/03/2021